CN Patent
CN103096716B — Btk抑制剂的苯磺酸盐
Assigned to Avila Therapeutics Inc · Expires 2016-03-02 · 10y expired
What this patent protects
本发明提供一种盐形式和其组合物,其适用作一种或一种以上蛋白质激酶的抑制剂并且展现所述抑制剂的所要特征。
USPTO Abstract
本发明提供一种盐形式和其组合物,其适用作一种或一种以上蛋白质激酶的抑制剂并且展现所述抑制剂的所要特征。
Drugs covered by this patent
- Wayrilz (RILZABRUTINIB) · Genzyme Corp
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.